A Real-World Evidence Study to Evaluate the Effects of Voltaren Use on Mobility and Quality of Life in Participants With Knee Osteoarthritis Pain - Trial NCT06379893
Access comprehensive clinical trial information for NCT06379893 through Pure Global AI's free database. This Phase 4 trial is sponsored by HALEON and is currently Recruiting. The study focuses on Pain. Target enrollment is 195 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
HALEON
Timeline & Enrollment
Phase 4
Apr 25, 2024
Nov 15, 2024
Primary Outcome
Change from Baseline in the Average Minutes of Moderate and Vigorous Physical Activity (MVPA) at Week 1,Change from Baseline in the Average Minutes of MVPA at Week 2,Change from Baseline in the Average Minutes of MVPA at Week 3
Summary
The purpose of this study is to investigate how topical diclofenac use can improve functional
 mobility and physical activity primarily, as well as other quality-of-life (QoL) parameters
 such as sleep, mood, and engagement in daily activities in participants with knee OA.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06379893
Non-Device Trial